Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Stomach Cancer
95%
Cisplatin
62%
Ulcerative Colitis
46%
Pancreas Cancer
40%
Chemoradiation Therapy
38%
Remission
34%
Overall Survival
34%
Malignant Neoplasm
31%
Esophagus Cancer
29%
First-Line Chemotherapy
24%
Gemcitabine
24%
Metastatic Colorectal Cancer
23%
Adsorption
23%
Mercaptopurine
23%
Crohn's Disease
23%
Paclitaxel
23%
Regorafenib
23%
Disease
22%
Progression Free Survival
21%
Adverse Event
18%
Clinical Trial
16%
Monoclonal Antibody
15%
Recurrent Disease
15%
Inflammatory Bowel Disease
15%
Cardiovascular Disease
14%
Colon Cancer
14%
Second-Line Chemotherapy
13%
Combination Therapy
13%
Anticarcinogen
12%
Gallbladder Cancer
11%
Lansoprazole
11%
Esophagus Carcinoma
11%
Cowden Syndrome
11%
Neuroendocrine Carcinoma
11%
Concanavalin A-Induced Hepatitis
11%
Colorectal Cancer
11%
Nephroblastoma
11%
Gastrointestinal Obstruction
11%
Active Metabolite
11%
Lymphangitis
11%
Immunosuppressive Agent
11%
Chronic Kidney Failure
11%
Dextran Sulfate Sodium-Induced Colitis
11%
Antibiotic Agent
11%
Leukemia
11%
Docetaxel
11%
Sorafenib
11%
Nonalcoholic Fatty Liver
11%
Kidney Disease
11%
Medicine and Dentistry
Neoplasm
37%
Esophageal Cancer
37%
Bleeding
23%
Gastrointestinal Cancer
23%
Gemcitabine
23%
Colorectal Cancer
23%
DNA Damage
23%
Kidney Function
23%
Urinary System
23%
DNA Methylation
23%
Stomach Cancer
21%
Cholangiocarcinoma
19%
Dendritic Cell
16%
Disease
16%
Gallbladder Cancer
15%
Neuroendocrine Carcinoma
15%
Chemoradiation Therapy
15%
Cancer Cell
15%
Malignant Neoplasm
15%
Nonalcoholic Fatty Liver
15%
Fluorescence in Situ Hybridization
14%
Colitis
13%
Docetaxel
13%
Cisplatin
13%
Mesenchymal-Epithelial Transition
13%
Endoscopic Mucosal Resection
13%
Epithelial Cell
13%
Computer Assisted Tomography
13%
Colon
12%
Bone Marrow Transplantation
12%
Lymph Node Metastasis
12%
Y Chromosome
11%
Side Population
11%
Tumor Microenvironment
11%
Side Population Cell
11%
Genome Sequencing
11%
Pericardial Fluid
11%
Fat Content
11%
Esophageal Squamous Cell Carcinoma
11%
Organoid
11%
Pleura Effusion
11%
Tumor Suppressor Gene
11%
Soft Tissue Sarcoma
11%
Alcohol Consumption
11%
Next Generation Sequencing
11%
Pazopanib
11%
Genetic Difference
11%
Lymphatic Tissue
11%
Lymphangitis
11%
Predictive Factor
11%
Keyphrases
Colitis
25%
T Helper 17 (Th17)
23%
Lymphocytes
23%
Crohn's Disease
23%
Ulcerative Colitis
23%
DNA Methylation Clock
23%
Urinary Shedding
23%
Gastrointestinal Cancer
19%
Interferon-α (IFN-α)
17%
CD4+
17%
Colon
15%
Japan
14%
Health Checkup
13%
Esophageal Cancer
13%
Interleukin-2
13%
Th1 Cells
13%
First-line Chemotherapy
13%
Colon Cancer Cells
12%
Colo205
12%
Monoclonal Antibody
12%
Bone Marrow Transplantation
12%
Osteosarcopenic Obesity
11%
Evidence-based Review
11%
Lansoprazole
11%
Gemcitabine Plus S-1
11%
Wilms' Tumor Gene
11%
Mitogen
11%
Colonic Hemangioma
11%
Small Cell Neuroendocrine Carcinoma
11%
Growing up
11%
Cisplatin Therapy
11%
Metabolic-associated Fatty Liver Disease (MAFLD)
11%
Post-progression Survival
11%
Mechanism of Action
11%
Advanced Gastric Cancer
11%
PANC-1
11%
Apoptosis Resistance
11%
Interleukin-17 (IL-17)
11%
Pleural Fluid Cytology
11%
Recurrent Pleural Effusion
11%
Anti-VEGF Therapy
11%
FOLFOXIRI
11%
Intestinal mucosa
11%
Malignant Bowel Obstruction
11%
Oral Anticancer Drugs
11%
Advanced Soft Tissue Sarcoma
11%
Lung Function
11%
Gemcitabine
11%
Lymphoid Tissue Inducer
11%
Bone Marrow Cells
11%
